As the Trump administration reshapes biomedicine, it wants to change how scientists test drug safety: animal research.

President Trump wants to make it easier to involuntarily treat people with serious mental illnesses, but critics say the ...

An unusual FDA panel on antidepressant use during pregnancy elevated clinicians and researchers who are deeply skeptical of ...

UnitedHealth Group on Thursday confirmed the Department of Justice has launched both criminal and civil investigations into ...

President Trump is threatening to withhold funds from supervised drug consumption sites and potentially pursue criminal ...

States are unlikely to fully neutralize the Medicaid cuts — but they have tools to scuttle the Trump administration's efforts ...

Former Biden global health security lead Stephanie Psaki asks: Why would the Trump administration reject a deal that ...

The H5N1 bird flu virus has historically extracted a heavy toll when it infects humans, with nearly half of confirmed cases ...

European regulators said that Eli Lilly’s Alzheimer’s treatment Kisunla should be approved for select patients.

But it’s unclear if the evidence provided to support continued use of fluoridated supplements will matter. The FDA said in ...

Preauthorization is about to enter the lives of many seniors who have chosen traditional Medicare over MA, write former CMS ...

Improvements in rural cancer care in Kentucky could be imperiled by President Trump's tax and domestic policy bill.